REDWOOD CITY, CA, September 30, 2026 /24-7PressRelease/ -- Dharti Tank has been selected for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Ms. Tank currently serves as the senior manager of regulatory affairs, CMC, at Gilead Sciences, Inc., a role she has held since 2025. In this capacity, she leverages her expertise in regulatory chemistry, manufacturing and controls to guide cross-functional teams and ensure compliance with global health authority requirements. Her responsibilities include developing strategies for regulatory submissions across product lifecycle and collaborating with various departments to streamline processes and facilitate the approval of innovative therapies. Additionally, Ms. Tank contributed to the development of templates and content frameworks supporting artificial intelligence-based tools for preparing regulatory documents demonstrating her forward-thinking approach to process improvement and adoption of emerging technologies within the biopharmaceutical industry.

Prior to joining Gilead Sciences, Inc., Ms. Tank applied her regulatory CMC expertise at Day One Biopharmaceuticals, Inc. in 2025, where she led the preparation of regulatory documentation and contributed to the regulatory development of critical oncology programs as they advanced through the development pipeline.

From 2022 to 2024, Ms. Tank served as Global Regulatory Affairs Manager, CMC (Biologics), at Amgen Inc., where she made significant contributions to the regulatory approval and post-approval management of key biologic products, supporting their continued development and lifecycle management. Her involvement extended beyond technical responsibilities; she frequently attended patient meetings, witnessing firsthand the positive impact of these treatments on individuals' lives. These experiences reinforced her sense of purpose and commitment to patient-centered innovation.

In 2022, Ms. Tank served as Senior Regulatory Specialist, CMC (Small Molecules and Biologics), at Omeros Corporation in Seattle, Washington, where she played an important role in managing complex regulatory submissions and supporting compliance with evolving regulatory and industry requirements. From 2020 to 2022, she served as Regulatory Specialist, CMC, at Omeros Corporation, further developing her expertise in regulatory dossier preparation for key small molecule and biologics programs.

Ms. Tank's earlier experience includes serving as a research scientist at Lazarus Naturals from 2019 to 2020, where she conducted research focused on product formulation and quality control. Between 2016 and 2018, she was a formulation scientist and regulatory associate at Akorn, Inc. in Cranbury, New Jersey, contributing to the development of various topical and ophthalmic pharmaceutical products while supporting regulatory compliance efforts.

Her career began as a scientist II at Amneal Pharmaceuticals LLC from 2014 to 2016, where she worked on product development projects for generic pharmaceuticals. In 2014, Ms. Tank started as a junior formulation scientist at Tedor Pharma Inc. in Cumberland, Rhode Island, gaining foundational experience in pharmaceutical research and development.

Throughout her career trajectory spanning more than a decade, Ms. Tank has demonstrated exceptional agility and adaptability—qualities that have enabled her to progress from bench scientist roles to strategic leadership positions interfacing with health authorities, finance teams and other stakeholders. Her ability to communicate effectively across departments has been vital in ensuring smooth collaboration and successful project outcomes.

Ms. Tank is recognized as an expert in regulatory chemistry, manufacturing and controls. She is an active member of the Regulatory Affairs Professionals Society and previously held membership with the Academy of Applied Pharmaceutical Sciences.

Her academic background includes a Master of Science in pharmaceutical sciences from Long Island University in Brooklyn, New York, earned in 2014. She also holds a Bachelor of Science in pharmacy from Veer Narmad South Gujarat University in Surat, India, completed in 2011. The rigorous training received during her studies provided a strong foundation for her technical expertise and strategic thinking within the biopharmaceutical sector.

Ms. Tank attributes her professional success to resilience and adaptability—traits she considers essential for navigating the fast-evolving landscape of pharmaceutical regulation. She emphasizes the importance of flexibility and perseverance when facing challenges, believing that positive outcomes are achievable through determination.

Beyond her professional commitments, Ms. Tank has been dedicated to civic engagement, volunteering with the American Cancer Society since 2018 and donating to St. Jude Children's Research Hospital. Her scholarly contributions include authoring "Investigate the effect of solvents on wet granulation of microcrystalline cellulose using hydroxypropyl methylcellulose as a binder and evaluation of rheological and thermal characteristics of granules," published by Elsevier in 2018, as well as "Nutraceuticals-Portmanteau of Science and Nature," featured in the International Journal of Pharmaceutical Sciences Review and Research in 2010.

In her personal life, Ms. Tank enjoys cooking and hiking. She is motivated by unmet patient needs—particularly those affecting rare disease or orphan-designated populations—and seeks opportunities to deliver treatments more efficiently without compromising safety or efficacy standards. Her ongoing objective is to develop strategies that address these gaps so that neglected patient groups receive timely access to essential therapies.

Ms. Tank's career reflects a steadfast commitment to scientific excellence, patient advocacy and continuous improvement within the biopharmaceutical industry.

# # #